CONTROLS TO MINIMIZE DISRUPTION OF THE PHARMACEUTICAL SUPPLY CHAIN DURING THE COVID-19 PANDEMIC

Anthony M Cundell; Dennis Edward Guilfoyle; T. R. Kreil; Anil Sawant

doi:10.5731/pdajpst.2020.012021

OtherPDA Paper

CONTROLS TO MINIMIZE DISRUPTION OF THE PHARMACEUTICAL SUPPLY CHAIN DURING THE COVID-19 PANDEMIC

Anthony M Cundell, Dennis Edward Guilfoyle, T. R. Kreil and Anil Sawant

PDA Journal of Pharmaceutical Science and Technology May 2020, pdajpst.2020.012021; DOI: https://doi.org/10.5731/pdajpst.2020.012021

Anthony M Cundell

1 Microbiological Consulting, LLC;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: tonycundell@gmail.com

Dennis Edward Guilfoyle

2 Johnson & Johnson;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: dguilfoy@its.jnj.com

T. R. Kreil

3 Takeda, Vienna, Austria;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anil Sawant

4 Merck & Co., Inc.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: anil.sawant@merck.com

Article
References
Info & Metrics
PDF

Article Information

pdajpst.2020.012021

DOI

https://doi.org/10.5731/pdajpst.2020.012021

PubMed

32467176

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Received May 22, 2020
Accepted May 22, 2020
Published online May 28, 2020.

Article Versions

You are currently viewing a previous version of this article (May 28, 2020 - 09:03).
View the most recent version of this article

Author Information

Anthony M Cundell1,5 (tonycundell{at}gmail.com),
Dennis Edward Guilfoyle2 (dguilfoy{at}its.jnj.com),
T. R. Kreil3 and
Anil Sawant4 (anil.sawant{at}merck.com)

¹ Microbiological Consulting, LLC;
² Johnson & Johnson;
³ Takeda, Vienna, Austria;
⁴ Merck & Co., Inc.

↵* Corresponding author; email: tonycundell{at}gmail.com

Cited By...

19 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Considerations for diagnostic COVID-19 tests

Olivier Vandenberg, Delphine Martiny, Olivier Rochas, Alex van Belkum, Zisis Kozlakidis

Nature Reviews Microbiology 2021 19 3
The Effects of the Health System Response to the COVID-19 Pandemic on Chronic Disease Management: A Narrative Review

Tetyana Kendzerska, David T Zhu, Andrea S Gershon, Jodi D Edwards, Cayden Peixoto, Rebecca Robillard, Claire E Kendall

Risk Management and Healthcare Policy 2021 Volume 14
Internet of Things (IoT)—blockchain-enabled pharmaceutical supply chain resilience in the post-pandemic era

Xiaohong Chen, Caicai He, Yan Chen, Zhiyuan Xie

Frontiers of Engineering Management 2023 10 1
Key performance indicators for a sustainable recovery strategy in health-care supply chains: COVID-19 pandemic perspective

Towfique Rahman, Md. Abdul Moktadir, Sanjoy Kumar Paul

Journal of Asia Business Studies 2022 16 3
Supply chain risk management strategies in normal and abnormal times: policymakers' role in reducing generic medicine shortages

Victoria Ahlqvist, Nonhlanhla Dube, Marianne Jahre, Jin Soo Lee, Tsegaye Melaku, Andreas Farstad Moe, Max Olivier, Kostas Selviaridis, Joe Viana, Christine Aardal

International Journal of Physical Distribution & Logistics Management 2023 53 2
Barriers to achieving sustainability in pharmaceutical supply chains in the post-COVID-19 era

Sharmine Akther Liza, Naimur Rahman Chowdhury, Sanjoy Kumar Paul, Mohammad Morshed, Shah Murtoza Morshed, M.A. Tanvir Bhuiyan, Md. Abdur Rahim

International Journal of Emerging Markets 2023 18 12
Sustainable supply chain operation under COVID-19: influences and response strategies

Zhen Li, Yingying Sheng, Qingfeng Meng, Xin Hu

International Journal of Logistics Research and Applications 2025 28 1
Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine

Natalie Thiel, Casey Selwyn, Georgina Murphy, Shmona Simpson, Ajoy C. Chakrabarti

npj Vaccines 2021 6 1
Shortages of Medicines to Treat COVID-19 Symptoms during the First Wave and Fourth Wave: Analysis of Notifications Reported to Registers in Austria, Italy, and Spain

Diana Ivonne Rodríguez Sánchez, Sabine Vogler

Pharmacy 2023 11 4
Benefits and probable ill effects of WHO’s declaration of end of COVID-19 pandemic: a way back to pandemic-free normal life

Rapty Sarker, A. S. M. Roknuzzaman, Nazmunnahar, Md. Jamal Hossain, Md. Rabiul Islam

Annals of Medicine & Surgery 2023 85 6
Classifying healthcare warehouses according to their performance. A Cluster Analysis-based approach

Anna Corinna Cagliano, Giulio Mangano, Carlo Rafele, Sabrina Grimaldi

The International Journal of Logistics Management 2022 33 1
Critical path activities in clinical trial setup and conduct: How to avoid bottlenecks and accelerate clinical trials

Linn Bieske, Maximillian Zinner, Florian Dahlhausen, Hubert Truebel

Drug Discovery Today 2023 28 10
COVID-19 in the Asia Pacific: impact on climate change, allergic diseases and One Health

Ruby Pawankar, Bernard Y Thong, Marysia Recto, Jiu-Yao Wang, Amir Hamzah Abdul Latiff, Ting-Fan Leung, Philip H Li, Rommel Crisenio M Lobo, Michela Lucas, Jae-Won Oh, Wasu Kamchaisatian, Mizuho Nagao, Iris Rengganis, Zarir F Udwadia, Raja Dhar, Sonomjamts Munkhbayarlakh, Logii Narantsetseg, Duy L Pham, Yuan Zhang, Luo Zhang

Asia Pacific Allergy 2023
“We face the same risk as the other health workers”: Perceptions and experiences of community pharmacists in Indonesia during the COVID-19 pandemic

Luh Putu Lila Wulandari, Mishal Khan, Ari Probandari, Neha Batura, Astri Ferdiana, Yusuf Ari Mashuri, Tri Wibawa, Dea Daraninggar, Berlian Kusuma Dewi, Ric Day, Stephen Jan, Gill Schierhout, Shunmay Yeung, Virginia Wiseman, Marco Liverani, Amrish Yashwant Baidjoe

PLOS Global Public Health 2022 2 7
A strategic response to COVID-19 induced supply chain disruption in South Africa’s pharmaceutical industry

Blessing Takawira, Emmanuel Mutambara

International Journal of Research in Business and Social Science (2147- 4478) 2023 12 8
AI and Machine Learning Impacts in Intelligent Supply Chain

Sunil Kumar, Digvijay Pandey, Sunil Kumar, Abhishek Dwivedi, Abhishek Kumar Mishra, Mohit Singh Chauhan

2024
Clinical review of substitutions or alternatives for critical chemotherapy drug shortages in hematologic malignancies

Jose Tinajero, Tanya Markary, Jason Chen, Vaibhav Agrawal, Dat Ngo

American Journal of Health-System Pharmacy 2025 82 5
Optimal pricing strategies and social welfare of a diabetic pharmaceutical supply chain under supply disruption risk

Mahyar Vafaeinejad, Ata Allah Taleizadeh, Arijit Bhattacharya, Kamyar Vafaeinejad

Frontiers of Engineering Management 2025
Supply Chain Risk and Disruption Management

Rajesh Kumar Singh

2023

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 79, Issue 1

January/February 2025

Table of Contents
Index by Author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following CONTROLS TO MINIMIZE DISRUPTION OF THE PHARMACEUTICAL SUPPLY CHAIN DURING THE COVID-19 PANDEMIC

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 14 + 6 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

CONTROLS TO MINIMIZE DISRUPTION OF THE PHARMACEUTICAL SUPPLY CHAIN DURING THE COVID-19 PANDEMIC

Anthony M Cundell, Dennis Edward Guilfoyle, T. R. Kreil, Anil Sawant

PDA Journal of Pharmaceutical Science and Technology May 2020, pdajpst.2020.012021; DOI: 10.5731/pdajpst.2020.012021

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

CONTROLS TO MINIMIZE DISRUPTION OF THE PHARMACEUTICAL SUPPLY CHAIN DURING THE COVID-19 PANDEMIC

Anthony M Cundell, Dennis Edward Guilfoyle, T. R. Kreil, Anil Sawant

PDA Journal of Pharmaceutical Science and Technology May 2020, pdajpst.2020.012021; DOI: 10.5731/pdajpst.2020.012021

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Lessons from a Pandemic: Maintaining Compliant GxP Surveillance Programs and Stable Pharmaceutical Supply

Google Scholar

Keywords

COVID-19 pandemic
SARS-CoV-2
Drug shortage
Risk assessment
Risk mitigation
Supply chain

Main menu

User menu

Search

CONTROLS TO MINIMIZE DISRUPTION OF THE PHARMACEUTICAL SUPPLY CHAIN DURING THE COVID-19 PANDEMIC

Article Information

Article Versions

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.